Enanta Pharmaceuticals
ENTA
#7451
Rank
โ‚ฌ0.36 B
Marketcap
12,54ย โ‚ฌ
Share price
3.62%
Change (1 day)
65.93%
Change (1 year)

Revenue for Enanta Pharmaceuticals (ENTA)

Revenue in 2025 (TTM): โ‚ฌ58.74 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ55.66 Million. In 2024 the company made a revenue of โ‚ฌ63.99 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ66.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Enanta Pharmaceuticals from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ58.74 M-8.2%
2024 โ‚ฌ63.99 M-3.91%
2023 โ‚ฌ66.59 M-12.98%
2022 โ‚ฌ76.53 M-6.78%
2021 โ‚ฌ82.1 M-0.65%
2020 โ‚ฌ82.63 M-50.73%
2019 โ‚ฌ0.16 B-19.52%
2018 โ‚ฌ0.20 B91.59%
2017 โ‚ฌ0.10 B127.72%
2016 โ‚ฌ47.76 M-60.38%
2015 โ‚ฌ0.12 B17.92%
2014 โ‚ฌ0.10 B2675.61%
2013 โ‚ฌ3.68 M-92.92%
2012 โ‚ฌ52.03 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AbbVie
ABBV
โ‚ฌ51.22 B 91,934.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ79.14 B 142,092.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ10.06 B 17,989.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ55.17 B 99,018.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.25 B 74,019.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.41 B 86,885.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland